Article
Novel pathogenic variant in the LCAT gene in a compound heterozygous patient with fish-eye disease and a mild phenotype.
Journal of clinical lipidology - 1 Jan 2025
Miyata Masaaki, Kuroda Masayuki, Miyoshi Junko, Kirinashizawa Mika, Nagasawa Rora, Yamamoto Misato, Akasaki Yuichi, Utatsu Kensuke, Maezawa Yoshiro, Yokote Koutaro, Ohishi Mitsuru
Abstract excerpt
BACKGROUND AND OBJECTIVE: Low high-density lipoprotein (HDL)-cholesterol and corneal opacity are associated with fish-eye disease (FED), familial lecithin:cholesterol acyltransferase (LCAT) deficiency (FLD), apolipoprotein AI deficiency, and Tangier disease. The differential diagnosis is made by clinical and biochemical tests. Measuring the LCAT activity is the ideal way to distinguish conditions caused by LCAT...
Topics
- Humans
- Phosphatidylcholine-Sterol O-Acyltransferase
- Heterozygote
- Lecithin Cholesterol Acyltransferase Deficiency
- Phenotype
- Female
- Male
- Adult
